Nuwellis, Inc. (NUWE)
0.152
+0.01
(+4.68%)
USD |
NASDAQ |
Jun 10, 16:00
0.1487
0.00 (0.00%)
After-Hours: 07:05
Nuwellis Enterprise Value : -1.409M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | -1.409M |
| June 09, 2026 | -1.427M |
| June 08, 2026 | -1.428M |
| June 05, 2026 | -1.369M |
| June 04, 2026 | -0.674M |
| June 03, 2026 | -0.5304M |
| June 02, 2026 | -0.2523M |
| June 01, 2026 | 0.0353M |
| May 29, 2026 | 0.2292M |
| May 28, 2026 | 0.4277M |
| May 27, 2026 | 0.1871M |
| May 26, 2026 | 0.5808M |
| May 22, 2026 | 0.9575M |
| May 21, 2026 | 0.8165M |
| May 20, 2026 | 0.7978M |
| May 19, 2026 | 0.7672M |
| May 18, 2026 | 0.7693M |
| May 15, 2026 | 0.8125M |
| May 14, 2026 | 0.8784M |
| May 13, 2026 | 0.9048M |
| May 12, 2026 | 0.9048M |
| May 11, 2026 | 0.9311M |
| May 08, 2026 | 1.063M |
| May 07, 2026 | 1.089M |
| May 06, 2026 | 1.063M |
| Date | Value |
|---|---|
| May 05, 2026 | 1.116M |
| May 04, 2026 | 1.142M |
| May 01, 2026 | 1.010M |
| April 30, 2026 | 1.168M |
| April 29, 2026 | 1.116M |
| April 28, 2026 | 1.116M |
| April 27, 2026 | 1.247M |
| April 24, 2026 | 1.300M |
| April 23, 2026 | 1.325M |
| April 22, 2026 | 1.208M |
| April 21, 2026 | 1.221M |
| April 20, 2026 | 1.247M |
| April 17, 2026 | 1.300M |
| April 16, 2026 | 1.326M |
| April 15, 2026 | 1.419M |
| April 14, 2026 | 1.432M |
| April 13, 2026 | 1.353M |
| April 10, 2026 | 1.050M |
| April 09, 2026 | 1.037M |
| April 08, 2026 | 1.037M |
| April 07, 2026 | 1.168M |
| April 06, 2026 | 1.063M |
| April 02, 2026 | 1.063M |
| April 01, 2026 | 1.063M |
| March 31, 2026 | 0.9575M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 182.71B |
| AngioDynamics, Inc. | 485.44M |
| Alphatec Holdings, Inc. | 1.722B |
| AtriCure, Inc. | 1.322B |
| Baxter International, Inc. | 18.13B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.541M |
| Revenue (Quarterly) | 2.403M |
| Total Expenses (Quarterly) | 6.944M |
| EPS Diluted (Quarterly) | -2.188 |
| Gross Profit Margin (Quarterly) | 70.08% |
| Profit Margin (Quarterly) | -189.0% |
| Earnings Yield | -42.18K% |
| Normalized Earnings Yield | -45945.00 |